SHANGHAI HENLIUS BIOTECH INC revenue breakdown overview

SHANGHAI HENLIUS BIOTECH INC revenue for the last year amounted to 5.94 B HKD, the most of which — 5.96 B HKD — came from its highest performing source at the moment, Biopharmaceutical, the year earlier bringing 3.74 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought SHANGHAI HENLIUS BIOTECH INC 5.32 B HKD, and the year before that — 3.30 B HKD.